For several years, investigators have been studying combinations that include ruxolitinib, sold as Jakafi, to treat ...

Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of patients, announced today that it has received clearance ...